SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cian Healthcare informs about disclosure

12 Oct 2023 Evaluate

Cian Healthcare has informed that the case titled ‘Shreeji Pharmachem Vs M/s Cian Healthcare Limited’ having Case No. C.P. (IB) - 149/2022 for initiation of CIRP against the Company by a Trade Creditor under Section 9 of Insolvency and Bankruptcy Code, 2016 was taken for hearing on 06th October, 2023 and Bench feels that there is possibility of amicable settlement of the matter. Order Copy given by the NCLT Mumbai bench is attached.

The above information is a part of company’s filings submitted to BSE.

Cian Healthcare Share Price

8.26 0.00 (0.00%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×